US to Speed Up Medicare Payments for New Medical Devices, Cutting Reimbursement Wait Times to Two Months
MDT is trading near its 52-week low of $79.93 (4.0% above the low).
Summary
US health regulators are reportedly set to announce a program to significantly accelerate Medicare payments for new medical devices, reducing reimbursement wait times from over a year to just two months. This policy change is a substantial win for major medical device manufacturers, including Medtronic and Johnson & Johnson, who have actively lobbied for such reforms to encourage innovation and investment. This development is particularly impactful for Medtronic, which recently completed the acquisition of CathWorks, as new devices from such ventures could benefit from a faster path to market and revenue generation. Traders should monitor the official announcement from the Centers for Medicare & Medicaid Services and the Food and Drug Administration for specific details on the program's scope and implementation, as it could materially improve the commercialization landscape for new medical technologies.
At the time of this announcement, MDT was trading at $83.10 on NYSE in the Life Sciences sector, with a market capitalization of approximately $106.8B. The 52-week trading range was $79.93 to $106.33. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.